AstraZeneca Results Presentation Deck

H1 and Q2 2023 results Conference call agenda 3 CEO Opening Remarks Financial Results Oncology BioPharmaceuticals Rare Disease CEO Closing Remarks, Q&A Pascal Soriot Chief Executive Officer Aradhana Sarin Chief Financial Officer Dave Fredrickson EVP, Oncology Business Ruud Dobber EVP, BioPharmaceuticals Business Marc Dunoyer Chief Executive Officer, Alexion Pascal Soriot Chief Executive Officer Susan Galbraith EVP, Oncology R&D Mene Pangalos EVP, BioPharmaceuticals R&D B

View entire presentation